InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Mueller John Patrick, Directeur. Officer active across 1 companies, notably Entasis Therapeutics Holdings Inc.. In total, 6 disclosures have been logged. The latest transaction was filed on 18 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
0125,000 shares0
Common Stock
SEC:0001104659-22-005422·
0125,000 shares0
Common Stock
SEC:0001104659-22-005422:0·
€9,9033,907 shares@ €2.5346100.0% of flow
Common Stock
SEC:0001104659-21-133628·
€9,9033,907 shares@ €2.534650.0% of flow
Common Stock
SEC:0001104659-21-133628:0·
025,000 shares0
Common Stock
SEC:0001104659-21-128062·
025,000 shares0
Common Stock
SEC:0001104659-21-128062:0·
6 of 6 declarations
About Mueller John Patrick
John Patrick Mueller is the Chief Development Officer at Entasis Therapeutics Holdings Inc. He plays a key role in the company's development strategy, focusing on innovation and product expansion. With extensive expertise in the pharmaceutical field, John is responsible for leading research and development efforts to enhance clinical outcomes. His commitment to scientific advancement and interdisciplinary collaboration is a significant asset for Entasis.
